ICT

   hellooo!

  Now we have divided the subject, which is ICT and I'll be working with the data protection. So in this post I am publishing some links as an introduction onto the topic and I'm also doing a brainstorm to have an idea about what I could be saying in my presentation.


http://www.techrepublic.com/article/10-things-you-can-do-to-protect-your-data/

https://www.expedient.com/how-we-help/goals/protect-data/

What is protect data?
http://searchstorage.techtarget.com/definition/data-protection

EXAM QUESTIONS

   hiiiiii!

    This time we are asked to create our own questions about the themes we've been working on for the exam.

   Short questions (2):

• What does the sentence "stem cells are pluripotent" mean?

It means that as stem cells don't have a particular function they can be grown into any specific tissue cell.

• What do scientist hope they could do with stem cellsin the future? 

 Scientist hope  to make personalized medicines and also understand how our body works both when is healthy and when is not.

      Long question(1):

• What are stem cells?

They are cells with no particular job which are pluripotent so that they have the ability to became any cell. And we distinguisse three types of them: adult stem cells, embryonic stem cells and incuded pluripotent stem cells.  

    Multiple choice questions(4):

1-Which is not a type of stem cell?

A.Embryonic

B.Somatic

C. Genetically modified

D.Induced Pluripotent

2-What does pluripotent mean?

1. With no specific function.
2. Full of colours.
3. Died cells
4. Small cells.

3- What can a stem cell do nowadays?

1. Replace damage parts of an organ.
2. Create new organs.
3. Protect our body from infection.
4. Kill bacteria

4- What are researchers trying to do with stem cells?

1. Create personalized medicine and understand our bodies.
2. Finish with all the ilnesses.
3. Create new gadgets to improve operations.
4. Discover pharmaceuticals  for animals.

Questionnaire

hiiii!
 Here I give you the link to my questionnaire

https://docs.google.com/forms/d/1gi0VxZ6SdNgKfXh9-h72Hn1v9i2Z67Pr2qH4S8dSK-4/edit

VIDEO

helloo!

In this third term we are asked to do a presentation with a video which is already done. We have to choose a video about our specific topic on genetics and present it in front of the class.

In this way we will be working and learning about genetics by ourselves so that we can explain easily the subject we have been working on to the rest. In adddition, we'll improve our naturallity while we are speaking for a public.

For doing that we have to take into account the following aspects: the rehearsal of the video, the control we have refering to the topic, the content of the video itself and how we are communicating that. 

 The topic I was given, is stem cells and here I give you the link of my video, hope you like itttt!

https://www.youtube.com/watch?v=evH0I7Coc54


        

Pharmaceutical Industry

          hii!

  As i told you in an earlier entry, we made the presentation about pharmaceutical industry and this was our work.


http://pharmaceuticalluberri.weebly.com/

EUROPEAN SCIENTIST WOMEN

  heeeeeello!
 We are asked again to do something releated to Europe, Science and Women.
And we decided to to a magazine Quizz.

 
The thing is that another group from the class has suggested a great idea, so we are all helping to make the project get ahead. For that we are taking some pictures of us an by editing them with the app callled PRISMA to make a comic. As it has to be releated with the topic, it's about a girl that becomes a superhero called superscgirl.

PRESENTATION 2

PAULA

Pharmaceutical industry

The pharmaceutical industry is a business sector dedicated to the manufacture, preparation and marketing of medicinal chemicals for the treatment and prevention of diseases.  Their job, is to create pharmaceutical drugs to treat, prevent or cure disease. Drugs are classified in various ways, for example, the level of control with distinguishes prescription drugs( the ones that you need the order of a doctor) from over the counter drugs (the ones we can consume ourselves).

Product approval

In the United States, new pharmaceutical products must be approved by the Food and Drug Administration (FDA) , in the case of Europe the European Medicines Agency, as being both safe and effective. This process generally involves agreement of an Investigational New Drug filing with enough pre-clinical facts to support proceeding with human experimentation.  Following DNA approval, three phases of progressively larger human clinical analysis may be conducted.

• Phase I generally studies toxicity using healthy volunteers.
• Phase II can include pharmacokinetics and dosing in patients.
• Phase III is a very large study of efficacy in the intended patient population.

Following the successful completion of phase III testing, a New Drug Application is submitted to the FDA. The FDA review the data and if the product is seen as having a positive benefit-risk estimation, approval to market the product can be sold.

A fourth phase of post-approval supervision  is also often required due to the fact that even the largest clinical doses  cannot effectively predict the possibility  of rare side-effects. In certain instances, its indication may need to be limited to particular patient groups, and in others the substance is removed  from the market completely.

A product must pass the threshold for cost-effectiveness if it is to be approved. Treatments must represent 'value for money' and a net benefit to society.

But do we know the process behind? The one about human guinea pigs?

Well, the ones testing any kind of new drugs that might be sold at the market one day are human, commonly callled, human guinea pigs (cobaya humana or conejillo de indias).  This practise with humans, involves they’re exposed to several health dangers and permanent side effects. People who volunteer for these trials can be anyone, from a healthy student who needs to make a little extra cash to a desperate cancer patient hoping an experimental drug really can help.

Ads asking for volunteers are everywhere, on the backs of buses and on Craigslist. Te guinea pigs sign a consent insuring they are concious abot the risks, try the drug and are given  money for that. In Spain, they are paid between 500 and 3000 euros depending on the centro de sanidad and the prueba.

This system was called into question last month when a clinical trial of a pain medication in France went horribly wrong. While the health ministry is still investigating what happened, five people were hospitalized and one volunteer died. All these volunteers started the study healthy and now some may leave with a permanent disability.

http://ethics.harvard.edu/pharmaceutical-industry-institutional-corruption-and-public-health
https://en.wikipedia.org/wiki/Drug_discovery

https://en.wikipedia.org/wiki/Drug_development

Investigation

At present the research in the laboratories of pharmaceutical companies focus their interest in finding improved treatments for cancer, diseases of the central nervous system, viral diseases such as acquired immunodeficiency syndrome (AIDS), arthritis and circulatory system diseases, which are the illnesses that mainly afflict developed countries, and ultimately, they generate more profit. Little research is done on the prevailing conditions of developing countries (eg Chagas disease in South America), because the return on investment in these markets is low.

The use of live animals in medical research is the subject of controversy. While pharmacists have developed and continue to develop techniques to prevent their use, live animals (mainly rats and mice) remain crucial for many procedures.